S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 RegenxbioCoherus BiosciencesAudentes TherapeuticsOrchard TherapeuticsMomenta Pharmaceuticals
SymbolNASDAQ:RGNXNASDAQ:CHRSNASDAQ:BOLDNASDAQ:ORTXNASDAQ:MNTA
Price Information
Current Price$39.23$19.06$27.09$12.58$14.15
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$79.13$32.57$39.99$25.14$23.63
% Upside from Price Target101.72% upside70.93% upside47.63% upside99.86% upside67.00% upside
Trade Information
Market Cap$1.44 billion$1.33 billion$1.24 billion$1.09 billion$1.43 billion
Beta0.822.941.79N/A2.03
Average Volume562,973976,521502,039162,913525,283
Sales & Book Value
Annual Revenue$218.51 million$1.56 millionN/A$2.08 million$75.59 million
Price / Sales6.61852.15N/A581.7618.48
Cashflow$2.89 per shareN/AN/AN/AN/A
Price / Cash13.55N/AN/AN/AN/A
Book Value$14.20 per share($0.57) per share($7.48) per share$3.63 per share$4.68 per share
Price / Book2.76-33.43N/A3.473.02
Profitability
Net Income$99.94 million$-209,340,000.00$-128,820,000.00$-230,490,000.00$-176,060,000.00
EPS$2.38($3.22)($3.40)($10.22)($2.03)
Trailing P/E Ratio16.48N/AN/AN/AN/A
Forward P/E RatioN/A15.24N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-88.57%N/AN/AN/A-324.41%
Return on Equity (ROE)-15.39%N/AN/AN/A-55.24%
Return on Assets (ROA)-14.50%-70.62%-38.09%N/A-41.51%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%N/AN/A0.07%N/A
Current Ratio14.58%3.36%14.38%7.89%7.59%
Quick Ratio14.58%3.29%14.38%7.89%7.59%
Ownership Information
Institutional Ownership Percentage79.48%95.46%98.26%63.00%96.29%
Insider Ownership Percentage13.80%18.20%5.30%N/A3.40%
Miscellaneous
Employees192232207180131
Shares Outstanding36.81 million69.76 million45.44 million96.19 million98.71 million
Next Earnings Date11/6/2019 (Estimated)11/6/2019 (Confirmed)11/5/2019 (Estimated)N/A11/6/2019 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable
 RegenxbioCoherus BiosciencesAudentes TherapeuticsOrchard TherapeuticsMomenta Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel